<SEC-DOCUMENT>0001193125-25-159942.txt : 20250716
<SEC-HEADER>0001193125-25-159942.hdr.sgml : 20250716
<ACCEPTANCE-DATETIME>20250716170729
ACCESSION NUMBER:		0001193125-25-159942
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250715
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250716
DATE AS OF CHANGE:		20250716

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Repare Therapeutics Inc.
		CENTRAL INDEX KEY:			0001808158
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39335
		FILM NUMBER:		251128036

	BUSINESS ADDRESS:	
		STREET 1:		7171 FREDERICK BANTING
		STREET 2:		SUITE 270, BUILDING 2
		CITY:			SAINT-LAURENT
		STATE:			A8
		ZIP:			H4S 1Z9
		BUSINESS PHONE:		(857) 412-7018

	MAIL ADDRESS:	
		STREET 1:		7171 FREDERICK BANTING
		STREET 2:		SUITE 270, BUILDING 2
		CITY:			SAINT-LAURENT
		STATE:			A8
		ZIP:			H4S 1Z9
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d944012d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rptx="http://www.reparerx.com/20250715" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityTaxIdentificationNumber" name="dei:EntityTaxIdentificationNumber" contextRef="duration_2025-07-15_to_2025-07-15">00-0000000</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey_duration_2025-07-15_to_2025-07-15" name="dei:EntityCentralIndexKey" contextRef="duration_2025-07-15_to_2025-07-15">0001808158</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_AmendmentFlag_duration_2025-07-15_to_2025-07-15" name="dei:AmendmentFlag" contextRef="duration_2025-07-15_to_2025-07-15">false</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="rptx-20250715.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-07-15_to_2025-07-15"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001808158</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-07-15</xbrli:startDate> <xbrli:endDate>2025-07-15</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div><p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p><p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="margin-top:9pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-07-15_to_2025-07-15" id="Fact_1">8-K</ix:nonNumeric></span></p><p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p><p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-07-15_to_2025-07-15" format="ixt:date-monthname-day-year-en" id="Fact_0">July&#160;15, 2025</ix:nonNumeric></p><p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="margin-top:9pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2025-07-15_to_2025-07-15" name="dei:EntityRegistrantName" id="ixv-300">Repare Therapeutics Inc.</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in Its Charter)</p><p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2025-07-15_to_2025-07-15" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="ixv-301">Qu&#233;bec</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric contextRef="duration_2025-07-15_to_2025-07-15" name="dei:EntityFileNumber" id="ixv-302">001-39335</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style=" -sec-ix-hidden:Hidden_dei_EntityTaxIdentificationNumber" id="Fact_2">Not applicable</span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr> </table><p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2025-07-15_to_2025-07-15" name="dei:EntityAddressAddressLine1" id="ixv-303">7171 Frederick-Banting, Building 2</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2025-07-15_to_2025-07-15" name="dei:EntityAddressAddressLine2" id="ixv-304">Suite 270</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric contextRef="duration_2025-07-15_to_2025-07-15" name="dei:EntityAddressCityOrTown" id="ixv-305">St-Laurent</ix:nonNumeric>,</span> <ix:nonNumeric contextRef="duration_2025-07-15_to_2025-07-15" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="ixv-306">Qu&#233;bec</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2025-07-15_to_2025-07-15" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="ixv-307">Canada</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2025-07-15_to_2025-07-15" name="dei:EntityAddressPostalZipCode" id="ixv-308">H4S&#160;1Z9</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Zip Code)</span></td></tr> </table><p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, Including Area Code: (<ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-07-15_to_2025-07-15" id="Fact_3">857</ix:nonNumeric>) <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-07-15_to_2025-07-15" id="Fact_4">412-7018</ix:nonNumeric></span></p><p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report.)</p><p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left"><ix:nonNumeric contextRef="duration_2025-07-15_to_2025-07-15" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="ixv-311">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left"><ix:nonNumeric contextRef="duration_2025-07-15_to_2025-07-15" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="ixv-312">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left"><ix:nonNumeric contextRef="duration_2025-07-15_to_2025-07-15" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="ixv-313">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left"><ix:nonNumeric contextRef="duration_2025-07-15_to_2025-07-15" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="ixv-314">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr> </table><p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Securities registered pursuant to Section&#160;12(b) of the Act:</p><p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-07-15_to_2025-07-15" name="dei:Security12bTitle" id="ixv-315">Common shares, no par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-07-15_to_2025-07-15" name="dei:TradingSymbol" id="ixv-316">RPTX</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric contextRef="duration_2025-07-15_to_2025-07-15" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-317">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr> </table><p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p><p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric contextRef="duration_2025-07-15_to_2025-07-15" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="ixv-318">&#9744;</ix:nonNumeric></p><p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p><p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;1.01</span></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement.</p></td></tr> </table><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;15, 2025, Repare Therapeutics Inc. (the &#8220;Company&#8221;) entered into an exclusive worldwide license agreement (the &#8220;Agreement&#8221;) with Debiopharm International S.A. (&#8220;Debiopharm&#8221;), a privately-owned, Swiss-based biopharmaceutical company, regarding the development and commercialization of the Company&#8217;s product candidate lunresertib.</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Agreement, the Company has granted Debiopharm a worldwide, exclusive, sublicenseable license to develop, manufacture, and commercialize therapeutic products that contains lunresertib as the sole active pharmaceutical agreement (collectively, a &#8220;Repare Product&#8221;) or that combine lunresertib with Debio 0123, Debiopharm&#8217;s WEE1 inhibitor, and/or any other Wee1 inhibitor controlled by Debiopharm (a &#8220;Combination Product&#8221;). Under the terms of the Agreement, the Company will receive a $10&#160;million upfront payment, and is eligible to receive up to $257&#160;million in potential clinical, regulatory, commercial and sales milestone payments, including up to $5&#160;million in potential near-term payments upon the potential achievement of a clinical milestone event, and single-digit royalties on global net sales of Repare Products and Combination Products sold by Debiopharm or its sublicensees. Subject to earlier expiration of the royalty term in specified cases of generic competition, royalties will be paid, on a <span style="white-space:nowrap"><span style="white-space:nowrap">country-by-country</span></span> and Repare <span style="white-space:nowrap">Product-by-Repare</span> Product or Combination <span style="white-space:nowrap"><span style="white-space:nowrap">Product-by-Combination</span></span> Product (as applicable) basis, until, at the earliest, the tenth anniversary of the first commercial sale of such Repare Product or Combination Product in such country.</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Debiopharm is obligated to use reasonable commercial efforts to develop, seek regulatory approval for, and commercialize a Repare Product or Combination Product in at least one indication in the United States, Japan and in specified European countries.</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless earlier terminated, the Agreement will expire on a <span style="white-space:nowrap"><span style="white-space:nowrap">country-by-country</span></span> and Repare <span style="white-space:nowrap">Product-by-Repare</span> Product or Combination <span style="white-space:nowrap"><span style="white-space:nowrap">Product-by-Combination</span></span> Product (as applicable) basis, upon the expiration of the last royalty term for the last Repare Product or Combination Product in any country worldwide. The Agreement may be terminated by Debiopharm, upon 90 days&#8217; prior written notice at any time prior to the first marketing authorization of a Repare Product or Combination Product, or upon 180 days&#8217; prior notice at any time after the first marketing authorization of a Repare Product or Combination Product if Debiopharm determines in its sole discretion that scientific, technical, regulatory or economic reasons provide grounds for Debiopharm to cease further pursuit of the purposes and objectives of the Agreement. Either party may, subject to specified cure periods, terminate the Agreement in the event of the other party&#8217;s uncured material breach. Either party may also terminate the Agreement under specified circumstances relating to the other party&#8217;s insolvency.</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company and Debiopharm originally entered into a clinical study and collaboration agreement in January 2024 to explore the synergy between lunresertib and Debio 0123. Debiopharm will assume sponsorship, including sole responsibility for all costs and expenses, of the ongoing Phase 1 MYTHIC clinical trial evaluating lunresertib in combination with Debio 0123 and take over existing and future development activities related to lunresertib.</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Agreement, a copy of which, subject to any applicable confidential treatment, will be filed as an exhibit to the Company&#8217;s Quarterly Report on Form <span style="white-space:nowrap">10-Q</span> for the period ending September&#160;30, 2025.</p><p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;7.01</span></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure.</p></td></tr> </table><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;15, 2025, the Company issued a press release announcing its entry into the Agreement and an update on the Company&#8217;s continued prioritization of <span style="white-space:nowrap">RP-3467</span> and <span style="white-space:nowrap">RP-1664.</span> A copy of the press release is furnished as Exhibit 99.1 to this Current Report and incorporated herein by reference.</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information in this Item 7.01, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section. The information contained herein and in the accompanying exhibit is not incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing.</p></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Cautionary Note Regarding Forward-Looking Statements</p><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Current Report on Form <span style="white-space:nowrap">8-K</span> contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, statements regarding the Agreement and the potential benefits to the Company from its entry into the Agreement; the Company&#8217;s potential to receive milestone payments and royalties under the Agreement; the development and potential commercialization of potential product candidates under the Agreement, including the development of any Repare Product or Combination Product; and the continued prioritization of the Company&#8217;s product candidates.</p><p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits.</p></td></tr></table><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Description</span></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d944012dex991.htm">Press release dated July&#160;15, 2025. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr></table></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:40%;border-spacing:0;margin-left:auto">
<tr>
<td style="width:7%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:92%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">REPARE THERAPEUTICS INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Steve Forte</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Steve Forte</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">President, Chief Executive Officer and</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Chief Financial Officer</p></td></tr></table></div><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: July&#160;16, 2025</p></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d944012dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g944012g0716210830553.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Repare Therapeutics Enters Exclusive Worldwide Licensing Agreement with Debiopharm for Lunresertib </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">July 15, 2025 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CAMBRIDGE, Mass. &amp; MONTREAL&#151;(BUSINESS <FONT
STYLE="white-space:nowrap">WIRE)--Jul.</FONT> 15, 2025&#151; Repare Therapeutics Inc. (&#147;Repare&#148; or the &#147;Company&#148;) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced it has entered into an exclusive
worldwide licensing agreement with Debiopharm International S.A. (&#147;Debiopharm&#148;), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow&#146;s standards of care to cure cancer and infectious diseases, for
lunresertib, a first-in-class precision oncology PKMYT1 inhibitor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The exclusive worldwide licensing agreement with Debiopharm allows for the
continued development of lunresertib, a novel PKMYT1 inhibitor, that has demonstrated encouraging results across multiple clinical trials in difficult-to-treat solid tumors. This agreement builds upon the success of Repare and Debiopharm&#146;s
existing collaboration studying the combination of lunresertib and Debio 0123,&#148; said Steve Forte, President, Chief Executive Officer and Chief Financial Officer of Repare. &#147;Our recent business development efforts have continued to enable
Repare to focus on the advancement of our clinical priorities and sustained value creation. We remain focused on two ongoing Phase 1 clinical trials with readouts expected in the second half of 2025: the LIONS trial evaluating our <FONT
STYLE="white-space:nowrap">RP-1664</FONT> PLK4 inhibitor and the POLAR trial evaluating our <FONT STYLE="white-space:nowrap">RP-3467</FONT> Pol&#952; ATPase inhibitor.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the agreement, Repare will receive a $10&nbsp;million upfront payment, and is eligible to receive up to $257&nbsp;million in potential
clinical, regulatory, commercial and sales milestones, including up to $5&nbsp;million in potential near-term payments, and single-digit royalties on global net sales. Repare and Debiopharm entered into a clinical study and collaboration agreement
in January 2024 to explore the synergy between lunresertib and Debio 0123, a potential <FONT STYLE="white-space:nowrap">best-in-class,</FONT> brain penetrant and highly selective WEE1 inhibitor. Debiopharm will assume sponsorship of the MYTHIC study
and take over existing and future development activities related to lunresertib. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are excited to enter into this worldwide license agreement with
Repare for lunresertib. Based on very promising Phase 1/1b clinical data, we believe the combination of lunresertib and Debio 0123 is highly synergistic and could potentially drive rapid and deep tumor regressions,&#148; said Bertrand Ducrey, CEO of
Debiopharm. &#147;We believe the synthetic lethality approach of lunresertib in combination with Debio 0123 will allow us to bring this innovative precision therapy to patients with difficult to treat cancers.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Continued Prioritization of <FONT STYLE="white-space:nowrap">RP-3467</FONT> and <FONT STYLE="white-space:nowrap">RP-1664</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moving forward, Repare will remain focused on the advancement of its two ongoing Phase 1 clinical trials, POLAR and LIONS. The POLAR clinical trial is a
multicenter, open-label, dose-escalation Phase 1 clinical trial designed to investigate the safety, pharmacokinetics, pharmacodynamics, and preliminary clinical activity of <FONT STYLE="white-space:nowrap">RP-3467,</FONT> a small molecule inhibitor
of polymerase theta (Pol&#952;) that is a synthetic lethality target associated with BRCA mutations and other genomic alterations, alone or in combination with olaparib in adults with locally advanced or metastatic epithelial ovarian cancer,
metastatic breast cancer, metastatic castration-resistant prostate cancer, or pancreatic adenocarcinoma. Topline safety, tolerability and early efficacy data from the Phase 1 POLAR clinical trial of <FONT STYLE="white-space:nowrap">RP-3467</FONT>
alone and in combination with olaparib is expected in the third quarter of 2025. The LIONS clinical trial is a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human,</FONT></FONT> multicenter, <FONT
STYLE="white-space:nowrap">open-label</FONT> Phase 1 clinical trial designed to investigate safety, pharmacokinetics, pharmacodynamics and the preliminary efficacy of <FONT STYLE="white-space:nowrap">RP-1664,</FONT> a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-class,</FONT></FONT> highly selective, oral inhibitor of <FONT STYLE="white-space:nowrap">Polo-like</FONT> kinase 4 (PLK4) that is a synthetic lethality target associated
with TRIM37 overexpression. Initial topline safety, tolerability and early efficacy data from the Phase 1 LIONS clinical trial of <FONT STYLE="white-space:nowrap">RP-1664</FONT> is expected in the fourth quarter of 2025. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Repare Therapeutics Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Repare Therapeutics is a <FONT
STYLE="white-space:nowrap">clinical-stage</FONT> precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. Repare Therapeutics has developed highly targeted cancer
therapies focused on genomic instability, including DNA damage repair. The Company&#146;s clinical-stage pipeline includes <FONT STYLE="white-space:nowrap">RP-3467,</FONT> a Phase 1 Pol&#952; ATPase inhibitor and
<FONT STYLE="white-space:nowrap">RP-1664,</FONT> a Phase 1 PLK4 inhibitor. For more information, please visit <U>w</U><U>w</U><U>w</U><U>.</U><U>re</U><U>p</U><U>a</U><U>r</U><U>er</U><U>x</U><U>.c</U><U>om</U> and follow @Reparerx on X (formerly
Twitter) and LinkedIn. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Debiopharm&#146;s Commitment to Patients </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Debiopharm aims to develop innovative therapies that target high unmet medical needs in oncology and bacterial infections. Bridging the gap between disruptive
discovery products and real-world patient reach, we identify high-potential compounds and technologies for <FONT STYLE="white-space:nowrap">in-licensing,</FONT> clinically demonstrate their safety and efficacy, and then hand stewardship to large
pharmaceutical commercialization partners to maximize patient access globally. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For more information, please visit
<U>www.</U><U>d</U><U>ebioph</U><U>a</U><U>rm.com</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Follow us, we are on <U>LinkedIn</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains
&#147;forward-looking statements&#148; within the meaning of the Private Securities Litigation Reform Act of 1995 and securities laws in Canada. All statements in this press release other than statements of historical facts are &#147;forward-looking
statements. These statements may be identified by words such as &#147;aims,&#148; &#147;anticipates,&#148; &#147;believes,&#148; &#147;could,&#148; &#147;estimates,&#148; &#147;expects,&#148; &#147;forecasts,&#148; &#147;goal,&#148;
&#147;intends,&#148; &#147;may,&#148; &#147;plans,&#148; &#147;possible,&#148; &#147;potential,&#148; &#147;seeks,&#148; &#147;will&#148; and variations of these words or similar expressions that are intended to identify forward-looking statements,
although not all forward-looking statements contain these words. Forward-looking statements in this press release include, but are not limited to, statements regarding: the Company&#146;s <FONT STYLE="white-space:nowrap">out-license</FONT> of
lunresertib to Debiopharm, including the potential benefits of the transaction and the achievement and receipt of milestone payments and royalties under the license agreement; the Company&#146;s anticipated cash runway; the timing, progress and
results of the Company&#146;s ongoing Phase 1 LIONS and POLAR clinical trials; and the potential, tolerability, efficacy and clinical progress of the Company&#146;s product candidates, including the potential of lunresertib to treat patients with <FONT
STYLE="white-space:nowrap">difficult-to-treat</FONT> solid tumors as a monotherapy or in combination with Debio </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">0123. These forward-looking statements are based on the Company&#146;s expectations and assumptions as of
the date of this press release. Each of these forward-looking statements involves risks and uncertainties that could cause the Company&#146;s clinical development programs, future results or performance to differ materially from those expressed or
implied by the <FONT STYLE="white-space:nowrap">forward-looking</FONT> statements. Many factors may cause differences between current expectations and actual results, including: the potential that success in preclinical testing and earlier clinical
trials does not ensure that later clinical trials will generate the same results or otherwise provide adequate data to demonstrate the efficacy and safety of a product candidate; the impacts of macroeconomic conditions, including tariffs and other
trade policies, the conflict in Ukraine and the conflict in the Middle East, fluctuations in inflation and uncertain credit and financial markets, on the Company&#146;s business, clinical trials and financial position; unexpected safety or efficacy
data observed during preclinical studies or clinical trials; clinical trial site activation or enrollment rates that are lower than expected; the Company&#146;s ability to realize the benefits of its collaboration and license agreements; changes in
expected or existing competition; changes in the regulatory environment; the uncertainties and timing of the regulatory approval process; and unexpected litigation or other disputes. Other factors that may cause the Company&#146;s actual results to
differ from those expressed or implied in the forward-looking statements in this press release are identified in the section titled &#147;Risk Factors&#148; in the Company&#146;s Annual Report on Form 10-K for the year ended December 31, 2024 filed
with the Securities and Exchange Commission (&#147;SEC&#148;) and the Qu&eacute;bec Autorit&eacute; des March&eacute;s Financiers (&#147;AMF&#148;) on March 3, 2025, and in other filings made with the SEC and AMF from time to time, including the
Company&#146;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025. The Company expressly disclaims any obligation to update any forward-looking statements contained herein, whether as a result of any new information, future events,
changed circumstances or otherwise, except as otherwise required by law. For more information, please visit <U>reparerx.com</U> and follow Repare on X (formerly Twitter) at @RepareRx and on LinkedIn at
<U>https://www.linkedin.com/company/repare-therapeutics</U>/. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View source version on <U>businesswire.com</U>:
<U>https://www.businesswire.com/news/home/20250715559714/en</U>/ </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Relations&nbsp;&amp; Media Contact: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Matthew DeYoung </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investor Relations and Media </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Argot Partners <U> </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>investors@reparerx.com</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Source: Repare Therapeutics Inc. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>rptx-20250715.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.1.4 -->
<!-- Creation date: 7/16/2025 3:28:48 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:rptx="http://www.reparerx.com/20250715"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:us-types="http://fasb.org/us-types/2024"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.reparerx.com/20250715"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2022-03-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rptx-20250715_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rptx-20250715_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>000001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>rptx-20250715_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.1.4 -->
<!-- Creation date: 7/16/2025 3:28:37 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line 1</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Address Line 1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line 2</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Address Line 2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Country</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Country</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>rptx-20250715_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.1.4 -->
<!-- Creation date: 7/16/2025 3:28:26 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="rptx-20250715.xsd#DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="26.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="26.031" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="26.131" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCountry" order="26.231" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="26.331" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="32.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g944012g0716210830553.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g944012g0716210830553.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  L (X# 2(  A$! Q$!_\0
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L1*(4*J%"J>Y/J:\^M+J7XF>*[W3]<(A33!((9+(>7(PW@89CG(]A@4 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jul. 15, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 15,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Repare Therapeutics Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">A8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39335<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">7171 Frederick-Banting, Building 2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address Address Line 2</a></td>
<td class="text">Suite 270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">St-Laurent<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">QC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address Country</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">H4S&#160;1Z9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">412-7018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common shares, no par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RPTX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001808158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d944012d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d944012d8k.htm">d944012d8k.htm</File>
    <File>rptx-20250715.xsd</File>
    <File>rptx-20250715_lab.xml</File>
    <File>rptx-20250715_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d944012d8k.htm": {
   "nsprefix": "rptx",
   "nsuri": "http://www.reparerx.com/20250715",
   "dts": {
    "inline": {
     "local": [
      "d944012d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "rptx-20250715.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "rptx-20250715_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rptx-20250715_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 24
   },
   "report": {
    "R1": {
     "role": "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "000001 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-07-15_to_2025-07-15",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d944012d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-07-15_to_2025-07-15",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d944012d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 1",
        "terseLabel": "Entity Address Address Line 1",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 2",
        "terseLabel": "Entity Address Address Line 2",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address City Or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Country",
        "terseLabel": "Entity Address Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.reparerx.com//20250715/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-25-159942-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-159942-xbrl.zip
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M?*BT-5\84!G/K)EA,UC>4#J[7I!'O2M#4GC3\1Y<<%!Z82!&]DEI(SKL#&]
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M6(C<)65R5YQ P*B82X0'.%3;(TND"/CR8?\4%+5;M;6$M/9]G@60@P\B)A&
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M4H%@:$12*$IYMA)D.E/HI_AGE(L.<=:E%#T9F41/($$\0V+M4L+^:9NO,9:
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MG63<Z0+SGO+ZB/DR;]WJDG\!4$L! A0#%     @ [8CP6@Y[X$@M%@  *8
M  X              ( !     &0Y-#0P,3)D.&LN:'1M4$L! A0#%     @
M[8CP6D3G Y6 $0  JC8  !$              ( !618  &0Y-#0P,3)D97@Y
M.3$N:'1M4$L! A0#%     @ [8CP6M/\)"?T @  \PD  !$
M ( !""@  ')P='@M,C R-3 W,34N>'-D4$L! A0#%     @ [8CP6ETUT1E]
M!@  7$D  !4              ( !*RL  ')P='@M,C R-3 W,35?;&%B+GAM
M;%!+ 0(4 Q0    ( .V(\%K@W#$_KP0  -HM   5              "  =LQ
M  !R<'1X+3(P,C4P-S$U7W!R92YX;6Q02P4&      4 !0!  0  O38

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>d944012d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rptx-20250715.xsd" xlink:type="simple"/>
    <context id="duration_2025-07-15_to_2025-07-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808158</identifier>
        </entity>
        <period>
            <startDate>2025-07-15</startDate>
            <endDate>2025-07-15</endDate>
        </period>
    </context>
    <dei:EntityTaxIdentificationNumber
      contextRef="duration_2025-07-15_to_2025-07-15"
      id="Hidden_dei_EntityTaxIdentificationNumber">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-07-15_to_2025-07-15"
      id="Hidden_dei_EntityCentralIndexKey_duration_2025-07-15_to_2025-07-15">0001808158</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="duration_2025-07-15_to_2025-07-15"
      id="Hidden_dei_AmendmentFlag_duration_2025-07-15_to_2025-07-15">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="duration_2025-07-15_to_2025-07-15" id="Fact_1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-07-15_to_2025-07-15" id="Fact_0">2025-07-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2025-07-15_to_2025-07-15" id="ixv-300">Repare Therapeutics Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-07-15_to_2025-07-15" id="ixv-301">A8</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-07-15_to_2025-07-15" id="ixv-302">001-39335</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-07-15_to_2025-07-15" id="ixv-303">7171 Frederick-Banting, Building 2</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2025-07-15_to_2025-07-15" id="ixv-304">Suite 270</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-07-15_to_2025-07-15" id="ixv-305">St-Laurent</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-07-15_to_2025-07-15" id="ixv-306">QC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressCountry contextRef="duration_2025-07-15_to_2025-07-15" id="ixv-307">CA</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-07-15_to_2025-07-15" id="ixv-308">H4S&#160;1Z9</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-07-15_to_2025-07-15" id="Fact_3">857</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-07-15_to_2025-07-15" id="Fact_4">412-7018</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-07-15_to_2025-07-15" id="ixv-311">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-07-15_to_2025-07-15" id="ixv-312">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-07-15_to_2025-07-15" id="ixv-313">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-07-15_to_2025-07-15" id="ixv-314">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2025-07-15_to_2025-07-15" id="ixv-315">Common shares, no par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2025-07-15_to_2025-07-15" id="ixv-316">RPTX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2025-07-15_to_2025-07-15" id="ixv-317">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-07-15_to_2025-07-15" id="ixv-318">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
